The European Commission estimates that 197,000 patients die each year from adverse drug reactions. This is partly due to differences in genetic make-up – what works well for Mr Brönnimann misses its target for Mrs Brönnimann or can lead to side effects. This influence can already be examined before the medication is administered, and an […]
About Kevin Tippenhauer
Kevin Tippenhauer is a medical informatics specialist FH and has been working as a research assistant for medical informatics at Bern University of Applied Sciences (BFH) since 2013. As part of the First Ventures project "Pharmacogenetic Decision Support" funded by the Gebert Rüf Foundation, Kevin Tippenhauer is working on simplifying the processes for pharmacogenetic interaction checks through IT support.